|
Submission ALP-POS-5de921e7
|
|
0
|
120
|
May 1, 2021
|
|
Submission CLI-TLC-0c07150b
|
|
0
|
152
|
April 29, 2021
|
|
Submission BRU-THA-55eab31a
|
|
0
|
126
|
April 29, 2021
|
|
Submission BRU-THA-73c97d88
|
|
0
|
143
|
April 29, 2021
|
|
Submission HYO-UNK-1dbfcf16
|
|
0
|
129
|
April 29, 2021
|
|
Submission MAT-POS-61f37a1a
|
|
0
|
134
|
April 29, 2021
|
|
Submission MAT-POS-14f31916
|
|
0
|
131
|
April 29, 2021
|
|
Submission CLI-TLC-0925f3e9
|
|
0
|
119
|
April 29, 2021
|
|
Submission CHR-MCD-2f2b3cc8
|
|
0
|
134
|
April 28, 2021
|
|
Submission EDG-MED-10fcb19e
|
|
3
|
210
|
April 28, 2021
|
|
Submission HYO-UNK-49a60884
|
|
0
|
125
|
April 28, 2021
|
|
Submission PET-UNK-bcc8fd08
|
|
0
|
129
|
April 28, 2021
|
|
Submission EDJ-MED-0047eae5
|
|
0
|
133
|
April 28, 2021
|
|
Submission CHE-UNK-3dacc16b
|
|
0
|
118
|
April 28, 2021
|
|
Submission ALP-POS-93b3621f
|
|
0
|
137
|
April 28, 2021
|
|
Submission EDJ-MED-cf877e1d
|
|
0
|
108
|
April 28, 2021
|
|
Submission EDJ-MED-139368ae
|
|
0
|
124
|
April 28, 2021
|
|
Submission J__-UNK-6ae33026
|
|
0
|
118
|
April 28, 2021
|
|
Submission MAT-POS-96f51285
|
|
2
|
176
|
April 28, 2021
|
|
Submission ALP-POS-e6e0c683
|
|
0
|
109
|
April 27, 2021
|
|
Submission EDJ-MED-6bf93aa8
|
|
0
|
113
|
April 27, 2021
|
|
Submission NIL-NON-a189c016
|
|
0
|
121
|
April 27, 2021
|
|
Submission JUL-NON-ff38eb21
|
|
0
|
119
|
April 27, 2021
|
|
Submission KAT-UNK-c8a6cb16
|
|
0
|
101
|
April 27, 2021
|
|
Submission HYO-UNK-1819783d
|
|
0
|
109
|
April 27, 2021
|
|
Submission EDJ-MED-b7309adf
|
|
0
|
123
|
April 26, 2021
|
|
Submission MAR-UNK-2ebea07b
|
|
0
|
118
|
April 26, 2021
|
|
Submission KAT-MCD-525c981a
|
|
0
|
106
|
April 26, 2021
|
|
Submission EDJ-MED-93390d0c
|
|
0
|
140
|
April 26, 2021
|
|
New antivirals, UK
|
|
1
|
215
|
April 26, 2021
|